Use of Zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases

Details for Australian Patent Application No. 2001261283 (hide)

Owner Novartis AG

Inventors Schran, Horst; Sigg, Juergen; Seaman, John J.

Agent Davies Collison Cave

Pub. Number AU-B-2001261283

PCT Pub. Number WO01/89494

Priority 0012209 19.05.00 GB

Filing date 9 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 13 January 2005

International Classifications

A61K 031/00

Event Publications

13 January 2005 Application Accepted

  Published as AU-B-2001261283

12 May 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001261284

2001261282